Carnegie Lake Advisors’s Pfizer PFE Stock Holding History

Carnegie Lake Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.19M	Sell	49,577 -1,941	-4%	-$50.8K	0.45%	55
2026 Q1	$1.45M	Sell	51,518 -1,767	-3%	-$47K	0.57%	44
2025 Q4	$1.33M	Sell	53,285 -8,913	-14%	-$225K	0.51%	49
2025 Q3	$1.58M	Buy	62,198 +636	+1%	+$15.7K	0.61%	43
2025 Q2	$1.49M	Sell	61,562 -2,397	-4%	-$55.9K	0.59%	47
2025 Q1	$1.62M	Buy	63,959 +1,595	+3%	+$41.7K	0.66%	42
2024 Q4	$1.66M	Buy	62,364 +800	+1%	+$21.7K	0.67%	43
2024 Q3	$1.78M	Buy	+61,564	New	+$1.8M	0.71%	37

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Carnegie Lake Advisors's PFE Position: Q2 2026 in Review

Carnegie Lake Advisors reduced its Pfizer (PFE) stake by 3.8% in Q2 2026, selling an estimated $50.8K and leaving 49,577 shares worth $1.19M. The position accounts for 0.45% of the portfolio, ranked #55.

Carnegie Lake Advisors first reported a position in PFE in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.78M in Q3 2024. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Carnegie Lake Advisors held 49,577 shares of Pfizer worth $1.19M as of Q2 2026.
Carnegie Lake Advisors sold 1,941 Pfizer shares in Q2 2026, an estimated $50.8K.
Pfizer made up 0.45% of Carnegie Lake Advisors's portfolio in Q2 2026, its #55 holding.
Carnegie Lake Advisors first reported a position in Pfizer in Q3 2024 and has held it in 8 quarters since.
Carnegie Lake Advisors's Pfizer position peaked at $1.78M in Q3 2024.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Carnegie Lake Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.